Intravaginal misoprostol 100 µg for cervical ripening and induction of labour in nulliparous women with term pregnancy and unfavourable cervix: a case series report
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20240142Keywords:
Cervical ripening, Labour induction, Misoprostol 100 µg, Nulliparous womenAbstract
Cervical ripening is a prerequisite for induction of labour in women adjudged to have an unfavourable cervix. Misoprostol administered intravaginally has previously been shown to be effective for cervical ripening and labour induction. It is often used in dosages of 25 µg or 50 µg in single or repeated dose regimen as per guidelines. Higher doses or shorter dosing intervals were reportedly associated with a higher incidence of side effects, especially uterine hyperstimulation syndrome. Studies and clinical experience have shown that 50 µg dose was not as effective in nulliparous women as it was in multiparous women, which implies that this dose might not be optimal for nulliparous women. We report a series of seven carefully selected patients in whom we used 100 µg of misoprostol intravaginally for cervical ripening and induction of labour at term. We achieved a short induction delivery interval, had good improvement in Bishop’s score, with less need for oxytocin augmentation and good safety parameters.
Metrics
References
Kwawukume EY. Induction and augmentation of labour. In: Kwawukume EY, Emuveyan EE (eds). Comprehensive Obstetrics in the Tropics. Asante and Hittscher Accra, Ghana. 2002;129-34.
Edwards RK, Richards DS. Preinduction cervical assessment. Clin Obstet Gynecol. 2000;43(4):440-6.
Garrett WJ. Prognostic signs in surgical induction of labor. Med J Aust. 1990;47(1):929-31.
Mozurkewich E, Chilimigas JL, Berman DR, Perni UC, Romero VC, King VJ et al. Methods of Induction of Labour: a systematic review. BMC Pregnancy Childbirth. 2011;11:84.
Kelly AJ, Kavanagh J, Thomas J. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev. 2003;CD003101.
Hofmeyr GJ, Gulmezoglu AM. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2003;CD000941.
Loto OM, Fadahunsi AA, Kolade CO. Safety and efficacy of misoprostol for induction of labour in a semi-urban hospital setting. J Obstet Gynaecol. 2004;24(6):638-40.
Ekele BA, Nnadi DC, Gana MA, Shehu CE, Ahmed Y, Nwobodo EI. Misoprostol use for cervical ripening and induction of labour in a Nigerian teaching hospital. Niger J Clin Pract. 2007;10(3):234-7.
Szczesny W, Sandvik L. Pre-induction cervical ripening with 25 microgram and 50 microgram vaginal misoprostol in 181 nulliparous parturient. J Matern Fetal Neonatal Med. 2009;22(3):265-8.
Adeniji OA, Oladokun A, Olayemi O, Adeniji OI, Odukogbe AA, Ogunbode O et al. Pre-induction cervical ripening: Transcervical foley catheter versus intravaginal misoprostol. J Obstetr Gynaecol. 2005;25(2):134-9.
Ezechi OC, Kalu BKE, Njokanma FO, Nwokoro CA, Okeke GCE. Vaginal misoprostol induction of labour: a Nigerian hospital experience. J Obstet Gynaecol. 2004;24(3):239-42.
Tan TC, Yan SY, Chua TM, Biswas A, Chong YS. A randomised controlled trial of low-dose misoprostol and dinoprostone vaginal pessaries for cervical priming. BJOG. 2010;117(10):1270-77.
Saxena P, Puri M, Bajai M, Mishra A, Trivedi SS. A randomized clinical trial to compare the efficacy of different doses of intravaginal misoprostol with intracervical dinoprostone for cervical ripening and labor induction. Eur J Med Pharmacological Sci. 2011;15(7):759-63.
Iqbal S, Perwaiz M, Sohail R. Comparison of Two Dosage Regimens of Vaginal Misoprostol for Induction of Labour at Term. Pak J Med Heal Sci. 2009;3(4):346-9.
Rockhead C, Fletcher H, Reid M, Morgan O. A comparison of two methods of labor induction with vaginal misoprostol. Int J Gynecol Obstetr. 2003;80(3):271-7.
Fletcher H, Mitchell S, Simeon D, Brown D. Intravaginal misoprostol versus dinoprostone as cervical ripening and labor-inducing agents. Obstet Gynecol. 1994;83(2):244-7.
Ozsoy M, Ozsoy D. Induction of labor with 50 and 100 microg of misoprostol: comparison of maternal and fetal outcomes. Eur J Obstet Gynecol Reprod Biol. 2004;113(1):41-4.